Immunogenicity and Safety Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) in Adults Aged 50 Years and Older

NCT00782431 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3208

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Vero cell derived, trivalent, seasonal influenza vaccine
BIOLOGICAL: Licensed egg-derived, trivalent seasonal influenza vaccine

Sponsor

Alachua Government Services, Inc.